Pain：针灸可有效预防偏头痛患上和加重

记者从日前在京开会讨论的2011年诊断国际上研讨会上谎称，首都医科大学自建北京中医医务工作人员诊断为中心经流行病学工作得出结论，传统的中医诊断疗法可理论上预防措施病症的复发和再加。涉及研究工作期刊近日刊登在国际上著名Medicine《咳嗽》上，成为中华人民共和国大陆首篇刊登于该杂志的流行病学工作期刊。该文还被国际上知名医学遗传学该机构 Faculty of 1000 medicine（千名医学家）附送。

据了解，作为诊断常见病之一，病症发病率高，且危害严重影响。目前为止，我国18岁~65岁青年人的病症发病率高达9.3%，且有急剧下降趋向于。诊断用药头痛在中华人民共和国已经有数千年的历史背景。北京中医医务工作人员诊断为中心自2004年所设头痛专家门诊，积极参与了基于“金针君乐亭”、学学弟子贺普仁等多位著名诊断学家治痛经验的头痛研究工作。

据该为中心主任君麟鹏引介，该工程建设实施单盲、双模拟、随机对照的形式，在国内外5家医务工作人员的诊断科共招募140名无短时期病症病患，随机分作两分组，分别为用药分组（诊断加安慰剂）和对照分组（假针加氟桂利嗪）。两分组病患每周诊断用药3次，每晚口服药物。近期，4时更，用药分组病症的理论上减缓率为59%，对照分组为40%；用药分组咳嗽月份最少下滑4.1天，对照分组最少下滑1.9天。16时更，用药分组理论上减缓率为56%，对照分组为37%；用药分组咳嗽月份最少下滑 4.1天，对照分组最少下滑2天。

研究工作工作人员据此确信，诊断可以作为病症的预防措施复发和再加的方法，其治果也比不上此前国外的涉及研究工作。由于其研究工作方法的新颖和重要性，该期刊还被国际上知名医学遗传学该机构“千名研究团队”附送。（生物谷 Bioon.com）

doi:10.1016/j.pain.2011.04.006PMC:PMID:

Efficacy of acupuncture for migraine prophylaxis: A single-blinded, double-dummy, randomized controlled trial

Lin-Peng Wang,Xiao-Zhe Zhang,Jia Guo,Hui-Lin Liu,Yan Zhang,Cun-Zhi Liu,Jing-Hong Yi,Li-Ping Wang,Ji-Ping Zhao,Shan-Shan Li

Summary This multicenter, double-dummy trial suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks. Abstract Insufficient clinical trial data were ailable to prove the efficacy of acupuncture for migraine prophylaxis. A multicenter, double-dummy, single-blinded, randomized controlled clinical trial was conducted at the outpatient departments of acupuncture at 5 hospitals in China to evaluate the effectiveness of acupuncture. A total of 140 patients with migraine without aura were recruited and assigned randomly to 2 different groups: the acupuncture group treated with verum acupuncture plus placebo and the control group treated with sham acupuncture plus flunarizine. Treated by acupuncture 3 times per week and drugs every night, patients from both groups were evaluated at week 0 (baseline), week 4, and week 16. The primary outcome was measured by the proportion of responders (defined as the proportion of patients with a reduction of migraine days by at least 50%). The secondary outcome measures included the number of migraine days, visual ogue scale (VAS, 0 to 10cm) for pain, as well as the physical and mental component summary scores of the 36-item short-form health survey (SF-36). The patients in the acupuncture group had better responder rates and fewer migraine days compared with the control group (P.05). The results suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks, whereas no significantly differences were found between acupuncture and flunarizine in reduction of pain intensity and improvement of the quality of life.